U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
The Parent Company was added by ICIJ.
The parent company information is based on 2017 public records.
Nuvectra is conducting a recall due to two clinical risks that are associated with certain percutaneous leads currently being used in the algovita spinal cord stimulation system.
it has been reported that in some percutaneous leads, the stylet protruded beyond the distal lead tip.
조치
Nuvectra field sales associate or contracted distributor were sent a Nuvectra Urgent Field Safety Notice (Field Action Number: 2016-03) on 10/11/2016 via Fed-Ex. The letter provided background information, described the problem, & the product involved in the recall. The letter listed the potential clinical implications, rate of occurrence, recommendations and mitigations and action needed. Provided consignees with notices for them to deliver to physicians as well as Response forms for them and the physician. For questions contact Kathy Jo Fahery +01.763.951.8219.
US: Nationwide (CA, TX, KY, FL, IL,PA,OH, GA, NJ, NC, KS, AR, CO, NE, NY, VA, AZ, OK). OUS: Germany
제품 설명
Algovita Spinal Cord Stimulation System, Percutaneous Leads, 8-Electrode Percutaneous Lead Kit; || Algovita Spinal Cord Stimulation System Percutaneous Leads, 12-Electrode Percutaneous Lead Kit; || Algovita Spinal Cord Stimulation System Percutaneous Trial Leads, 8-electrode Lead Kit; || Algovita Spinal Cord Stimulation System Percutaneous Trial Leads, 12-electrode Lead Kit. || Model Number (s) 112x-xx (CT), 108x-xx(T). || These are part of the Algovita Spinal Cord Stimulation System. || The Algovita Spinal Cord Stimulation system consists of a stimulator (EPG or IPG) that is physically and electrically connected to one or more leads inserted into the patient s spinal epidural space. The lead delivers electrical stimulation originating at the stimulator with the purpose of blocking pain signals going to the patient s brain. The stimulators are rechargeable, and the frequency of recharging is dependent on || individual patient s use of the system.